Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs over 1% as AI-linked stocks recover ahead of key earnings
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Oil edges higher as investors weigh renewed Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| (NASDAQ: KNSA) | Delayed: 79.14 +0.55 (0.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $78.59 | 52 Week High | $ | |||
| Open | $78.78 | 52 Week Low | $ | |||
| Day High | $80.61 | P/E | N/A | |||
| Day Low | $78.36 | EPS | $ | |||
| Volume | 254,816 | |||||
